Rhodomyrtosone D
Rhodomyrtosone D is a natural α-glucosidase and BCL-2 inhibitor. Rhodomyrtosone D exhibits an IC50 of 110.45 μg/mL against α-glucosidase derived from Saccharomyces cerevisiae. Rhodomyrtosone D interferes with carbohydrate digestion, interacts with specific BCL-2 amino acid residues, and reduces postprandial blood glucose levels. Rhodomyrtosone D can be used in the research of diabetes and breast cancer.
For research use only. We do not sell to patients.
- CAS No.: 1079988-19-4
- Formula: C25H32O6
- Molecular Weight:428.52
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Bcl-2 |
α-Glucosidase 110.45 μg/mL (IC50) |
Rhodomyrtosone D (0.24-30.77 µg/mL; 5 min preincubation, 30 min incubation with enzyme) inhibits α-glucosidase from Saccharomyces cerevisiae with an IC50 of 110.45 µg/mL, demonstrating stronger inhibitory activity than acarbose[1].
Rhodomyrtosone D shows in silico potential as an inhibitor of human BCL-xL (PDB 2w3l), with a docking score of -80.0479, and shares 50% of key interacting residues with the native ligand[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1079988-19-4
-
Molecular Weight 428.52
-
Formula C25H32O6
-
SMILES
CC([C@@]12[C@@](C3=C(C(C)(C(C(C)(C3=O)C)=O)C)O2)([H])C4=C(C(C)(C(C(C)(C4=O)C)=O)C)O1)C
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)